loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

SYMBIOTEC PHARMALAB IPO

UPCOMING

IPO Details

24th Aug 2026
27th Aug 2026
15
₹ 14,070
₹ 938-988
₹ 1757 Crore

Issue timeline

  • 24-27 Aug 2026
  • 28-Aug-2026
  • 31-Aug-2026
  • 31-Aug-2026
  • 01-Sep-2026

About Company

Symbiotec Pharmalab was incorporated on September 20, 2002. The company is an R&D-driven;, science-based pharmaceutical and biotechnology player with capabilities in organic chemistry, biotechnology, and complex injectables, and a global leadership position in corticosteroid and steroidal-hormone APIs. It is the only Indian and global company present across the top 10 such APIs in FY25, manufacturing them through fermentation and complex multi-step chemical processes
-
Name Designation
Anil Satwani Chairman & Managing Director
Rohit Mantri Nominee Director
Hariharnath Buggana Nominee Director
Sunita Kishnani Non-Executive Independent Director
Pratik Patel Non-Executive Independent Director
Richard Patrick Findlay Kenny Non-Executive Independent Director

Objectives

Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the company
General corporate purposes

Strengths & Risks

Strengths (3)

As of June 30, 2025, the company served over 200 customers across 40+ countries, including leading generic and specialty pharmaceutical companies, supported by strong quality assurance and consistent API supply. Its customer base has expanded steadily, with significant additions over the last three fiscals, strengthening its global commercial footprint

Risks (3)

The company’s manufacturing facilities are subject to regular regulatory and customer audits, and any quality or compliance failure could lead to regulatory action, reputational damage, and adverse impacts on operations and financial performance. Maintaining evolving certifications requires significant time, expertise, and investment, and is critical for market access and customer trust

Financials

Frequently Asked Questions

What is the minimum and maximum application amount for Symbiotec Pharmalab Ltd.’s issue?

For all category investors, the minimum application amount for this IPO is Rs. 14,070.0, the maximum value for this IPO is Rs 192,660.0.

This IPO will be allotted on Aug 28, 2026.

The refund will be credited to your account on Aug 31, 2026.

The allotted shares will be credited to your demat on Aug 31, 2026.

Symbiotec Pharmalab Ltd.’s shares will list on the stock exchanges on Sep 01, 2026.

View More

*The financials mentioned above are sourced from DRHP/ RHP documents.